Article Text

other Versions

Download PDFPDF
Cervical versus endometrial injection for sentinel lymph node detection in endometrial cancer: a randomized clinical trial
  1. Şener Gezer1,
  2. Seda Duman Öztürk2,
  3. Turkay Hekimsoy3,
  4. Çiğdem Vural2,
  5. Serkan İşgören3,
  6. İzzet Yücesoy1 and
  7. Aydın Çorakçı1
  1. 1Department of Obstetrics and Gynecology, Kocaeli University School of Medicine, Kocaeli, Turkey
  2. 2Department of Pathology, Kocaeli University School of Medicine, Kocaeli, Turkey
  3. 3Department of Nuclear Medicine, Kocaeli University School of Medicine, Kocaeli, Turkey
  1. Correspondence to Dr Şener Gezer, Department of Obstetrics and Gynecology, Kocaeli University School of Medicine, Kocaeli 41001, Turkey; dr.senergezer{at}gmail.com

Abstract

Objective To evaluate the relationship between pelvic/para-aortic sentinel lymph node status and two different injection sites of 99m-technetium (99mTc)-labeled phytate in patients with endometrial cancer.

Methods This was a randomized controlled trial involving 81 patients with endometrial cancer. In the cervical group (n=40), injections of 99mTc were performed at the 3 and 9 o’clock positions of the uterine cervix. In the endometrial group (n=41), 99mTc was injected into the fundal endometrium using a transcervical catheter. Sentinel lymph nodes were detected through pre-operative lymphoscintigraphy and intra-operatively using a handheld gamma probe. All patients underwent complete pelvic and para-aortic lymphadenectomy procedures. Pathologic ultra-staging was performed with immunostaining for cytokeratin in sentinel lymph nodes after routine hematoxylin and eosin histological examinations. The primary endpoint was the estimation of detection rates, sensitivity, false-negative rates, negative predictive value, and analysis of the distribution of pelvic and para-aortic sentinel lymph nodes.

Results The rate of detection of at least one sentinel lymph node, sensitivity, and the negative predictive value was 80%, 66.6%, 96.6% for the cervical group and 85%, 66.6%, 96.9% for the endometrial group, respectively. False-negative sentinel lymph nodes were detected in one patient from each group . There was no significant difference between the groups in terms of total sentinel lymph node count, sentinel pelvic lymph node count, and pelvic bilaterality, but the para-aortic sentinel lymph node count was significantly higher in the endometrial group (p<0.001). Ultra-staging examination of the pelvic sentinel lymph nodes revealed isolated tumor cells in one patient from each group.

Conclusion Transcervical endometrial tracer injection in endometrial cancer revealed similar pelvic but significantly higher para-aortic sentinel lymph node detection.

  • sentinel lymph node
  • endometrial neoplasms
  • lymphatic metastasis
View Full Text

Statistics from Altmetric.com

Footnotes

  • Editor's note This paper will feature in a special issue on sentinel lymph node mapping in 2020.

  • Contributors ŞG, Sİ, İY, and AÇ conceived and designed the study. SDÖ, TH, and ÇV were involved in data acquisition. ŞG analyzed the data. All authors were involved in the interpretation of data, drafting of the manuscript, and provided critical feedback. All authors approved the final manuscript.

  • Funding This study was funded by Kocaeli University Scientific Research Projects (2018/HD 109).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.